Clinical Significance of Candida tropicalis in Pediatric Patients with Invasive Candidiasis
- PMID: 40323062
- DOI: 10.1097/INF.0000000000004847
Clinical Significance of Candida tropicalis in Pediatric Patients with Invasive Candidiasis
Conflict of interest statement
The authors have no funding or conflicts of interest to disclose.
References
-
- Said AM, Afridi F, Redell MS, et al. Invasive candidiasis in pediatric hematologic malignancy: increased risk of dissemination with Candida tropicalis . Pediatr Infect Dis J. 2025;44:58–63.
-
- Keighley C, Kim HY, Kidd S, et al. Candida tropicalis-A systematic review to inform the World Health Organization of a fungal priority pathogens list. Med Mycol. 2024;62:myae040.
-
- Deorukhkar SC, Saini S, Mathew S. Virulence factors contributing to pathogenicity of Candida tropicalis and its antifungal susceptibility profile. Int J Microbiol. 2014;2014:456878.
-
- Arastehfar A, Daneshnia F, Hafez A, et al. Antifungal susceptibility, genotyping, resistance mechanism, and clinical profile of Candida tropicalis blood isolates. Med Mycol. 2020;58:766–773.
-
- Fernández-Ruiz M, Puig-Asensio M, Guinea J, et al.; CANDIPOP Project. Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance. J Infect. 2015;71:385–394.
LinkOut - more resources
Full Text Sources